Stemline Therapeutics Reports Second Quarter 2017 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/5/2026
- Dow jumps to record closing high after soft US jobs data, Nasdaq down with chip shares
- Goldman's Garrett sees investors dialing back tech exposure into H2
- AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
- Oil gains on short-covering buys ahead of US holiday
- Rivian stock jumps 5% on raised delivery outlook
Stemline Therapeutics (STML) Reports Q2 Loss of $0.66/Share
August 8, 2017 7:25 AM EDTStemline Therapeutics (NASDAQ: STML) reported Q2 EPS of ($0.66), versus ($0.52) reported last year.
For earnings history and earnings-related data on Stemline Therapeutics (STML) click here.
... More